Good Cells is an innovative biotechnological company engaged in research, development, and application of methods for regenerating diseased organs, damaged tissues, and depleted resources of the immune and energy systems of the body. Its foundation is based on the scientific discoveries of Nobel Prize laureates of 1990, 2002, 2007, and 2012.
Good Cells Laboratory operates according to international regulations for the USA, Europe, and Japan: GMP is a guarantee of absolute safety of pharmaceutical products for patients.
The staff includes 10 medical experts: doctors, biotechnologists, honored specialists and PhD holders, as well as university lecturers with at least 12 years of experience. The team has published 177 scientific articles in Ukrainian, German, and British journals. The latest study was published in the international journal BMC.
Five Ukrainian patents registered by Good Cells Laboratory have undergone expert evaluation and received approval and registration by the FDA (U.S. Food and Drug Administration). Since 2012, the company has entered the global market with the development of cell products.